Mechanistically, by acting as an agonist of the adrenergic β receptor 2 (β2-AR) (7), PAGln can potentiate platelet reactivity/thrombosis in arterial injury models and enhance spontaneous calcium release linked to AF (34). Here, ADRB2 is linked to atrial fibrillation.